CA2128190A1 - Methode d'identification de tissus - Google Patents

Methode d'identification de tissus

Info

Publication number: CA2128190A1
Authority: CA; Canada
Prior art keywords: tissue; infrared; malignant; normal; tissues
Prior art date: 1994-07-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2128190

Other languages

English (en)

Inventor

Patrick T.T. Wong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

National Research Council of Canada

Original Assignee

National Research Council of Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-15

Filing date

1994-07-15

Publication date

1996-01-16

1994-07-15 Application filed by National Research Council of Canada filed Critical National Research Council of Canada

1994-07-15 Priority to CA 2128190 priority Critical patent/CA2128190A1/fr

1996-01-16 Publication of CA2128190A1 publication Critical patent/CA2128190A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 24
238000002329 infrared spectrum Methods 0.000 claims abstract description 100
210000001519 tissue Anatomy 0.000 claims description 183
210000000981 epithelium Anatomy 0.000 claims description 105
230000003211 malignant effect Effects 0.000 claims description 104
210000002808 connective tissue Anatomy 0.000 claims description 91
210000001072 colon Anatomy 0.000 claims description 35
238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims description 9
230000015654 memory Effects 0.000 claims description 9
210000004400 mucous membrane Anatomy 0.000 claims description 7
238000001228 spectrum Methods 0.000 description 68
210000004027 cell Anatomy 0.000 description 49
102000004169 proteins and genes Human genes 0.000 description 39
108090000623 proteins and genes Proteins 0.000 description 39
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 29
150000001408 amides Chemical class 0.000 description 24
210000004877 mucosa Anatomy 0.000 description 23
102000039446 nucleic acids Human genes 0.000 description 21
108020004707 nucleic acids Proteins 0.000 description 21
150000007523 nucleic acids Chemical class 0.000 description 21
230000007423 decrease Effects 0.000 description 18
150000002632 lipids Chemical class 0.000 description 18
210000003679 cervix uteri Anatomy 0.000 description 17
150000004713 phosphodiesters Chemical group 0.000 description 17
102000008186 Collagen Human genes 0.000 description 14
108010035532 Collagen Proteins 0.000 description 14
229910019142 PO4 Inorganic materials 0.000 description 13
239000010452 phosphate Substances 0.000 description 13
201000011510 cancer Diseases 0.000 description 12
239000001257 hydrogen Substances 0.000 description 12
229910052739 hydrogen Inorganic materials 0.000 description 12
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 12
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
206010028980 Neoplasm Diseases 0.000 description 10
230000000112 colonic effect Effects 0.000 description 10
229920002527 Glycogen Polymers 0.000 description 9
238000004566 IR spectroscopy Methods 0.000 description 9
230000001413 cellular effect Effects 0.000 description 9
229940096919 glycogen Drugs 0.000 description 9
239000000835 fiber Substances 0.000 description 8
210000004379 membrane Anatomy 0.000 description 8
239000012528 membrane Substances 0.000 description 8
210000004953 colonic tissue Anatomy 0.000 description 7
206010008342 Cervix carcinoma Diseases 0.000 description 6
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 6
238000005452 bending Methods 0.000 description 6
201000010881 cervical cancer Diseases 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
210000000056 organ Anatomy 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
229910014033 C-OH Inorganic materials 0.000 description 5
102000012422 Collagen Type I Human genes 0.000 description 5
108010022452 Collagen Type I Proteins 0.000 description 5
206010009944 Colon cancer Diseases 0.000 description 5
229910014570 C—OH Inorganic materials 0.000 description 5
150000001720 carbohydrates Chemical class 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
230000009878 intermolecular interaction Effects 0.000 description 5
238000012856 packing Methods 0.000 description 5
125000003368 amide group Chemical group 0.000 description 4
238000001574 biopsy Methods 0.000 description 4
231100000504 carcinogenesis Toxicity 0.000 description 4
208000029742 colonic neoplasm Diseases 0.000 description 4
230000000762 glandular Effects 0.000 description 4
230000003993 interaction Effects 0.000 description 4
230000036210 malignancy Effects 0.000 description 4
230000026731 phosphorylation Effects 0.000 description 4
238000006366 phosphorylation reaction Methods 0.000 description 4
239000010453 quartz Substances 0.000 description 4
238000002271 resection Methods 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
208000005623 Carcinogenesis Diseases 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
206010064912 Malignant transformation Diseases 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000002776 aggregation Effects 0.000 description 3
238000004220 aggregation Methods 0.000 description 3
230000036952 cancer formation Effects 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
102000034238 globular proteins Human genes 0.000 description 3
108091005896 globular proteins Proteins 0.000 description 3
230000033001 locomotion Effects 0.000 description 3
230000036212 malign transformation Effects 0.000 description 3
230000003595 spectral effect Effects 0.000 description 3
QEMSVZNTSXPFJA-HNAYVOBHSA-N 1-[(1s,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol Chemical compound C1([C@H](O)[C@H](C)N2CCC(O)(CC2)C=2C=CC=CC=2)=CC=C(O)C=C1 QEMSVZNTSXPFJA-HNAYVOBHSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000000503 Collagen Type II Human genes 0.000 description 2
108010041390 Collagen Type II Proteins 0.000 description 2
229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 2
108010081750 Reticulin Proteins 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000001680 brushing effect Effects 0.000 description 2
MCMSPRNYOJJPIZ-UHFFFAOYSA-N cadmium;mercury;tellurium Chemical compound [Cd]=[Te]=[Hg] MCMSPRNYOJJPIZ-UHFFFAOYSA-N 0.000 description 2
230000008859 change Effects 0.000 description 2
210000001608 connective tissue cell Anatomy 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000010432 diamond Substances 0.000 description 2
229910003460 diamond Inorganic materials 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000005081 epithelial layer Anatomy 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000037361 pathway Effects 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
230000008569 process Effects 0.000 description 2
230000009467 reduction Effects 0.000 description 2
238000007790 scraping Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000007704 transition Effects 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
206010058314 Dysplasia Diseases 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
208000035346 Margins of Excision Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
208000006994 Precancerous Conditions Diseases 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000006399 behavior Effects 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
238000005460 biophysical method Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
210000004177 elastic tissue Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000009499 grossing Methods 0.000 description 1
230000002706 hydrostatic effect Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
208000029565 malignant colon neoplasm Diseases 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000003387 muscular Effects 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000007170 pathology Effects 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000004845 protein aggregation Effects 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
230000000007 visual effect Effects 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material

Landscapes

Physics & Mathematics (AREA)
Spectroscopy & Molecular Physics (AREA)
General Physics & Mathematics (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)

CA 2128190 1994-07-15 1994-07-15 Methode d'identification de tissus Abandoned CA2128190A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2128190 CA2128190A1 (fr)	1994-07-15	1994-07-15	Methode d'identification de tissus

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2128190 CA2128190A1 (fr)	1994-07-15	1994-07-15	Methode d'identification de tissus

Publications (1)

Publication Number	Publication Date
CA2128190A1 true CA2128190A1 (fr)	1996-01-16

Family

ID=4154015

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2128190 Abandoned CA2128190A1 (fr)	1994-07-15	1994-07-15	Methode d'identification de tissus

Country Status (1)

Country	Link
CA (1)	CA2128190A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2133023A1 (fr) *	2008-06-11	2009-12-16	Sumitomo Electric Industries, Ltd.	Dispositif et procédé de discrimination de tissu vital
CN107655847A (zh) *	2017-11-17	2018-02-02	黑龙江八农垦大学	针对难分辨中草药的利用红外光谱进行可视化表达的方法

1994
- 1994-07-15 CA CA 2128190 patent/CA2128190A1/fr not_active Abandoned

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2133023A1 (fr) *	2008-06-11	2009-12-16	Sumitomo Electric Industries, Ltd.	Dispositif et procédé de discrimination de tissu vital
CN107655847A (zh) *	2017-11-17	2018-02-02	黑龙江八农垦大学	针对难分辨中草药的利用红外光谱进行可视化表达的方法

Legal Events

Date	Code	Title	Description
1997-07-15	FZDE	Dead

Publication	Publication Date	Title
US5539207A (en)	1996-07-23	Method of identifying tissue
Wong et al.	1993	Pressure-tuning FT-IR study of human cervical tissues
Ci et al.	1999	Fourier transform infrared spectroscopic characterization of human breast tissue: implications for breast cancer diagnosis
US6954667B2 (en)	2005-10-11	Method for Raman chemical imaging and characterization of calcification in tissue
CA2008831C (fr)	1996-03-26	Methode de spectroscopie a infrarouge pour la detection de la presence d'anomalies dans les tissus biologiques et les cellules sous forme naturelle ou cultivees
Mahadevan-Jansen et al.	1996	Raman spectroscopy for the detection of cancers and precancers
Simonova et al.	2013	Application of Fourier transform infrared spectroscopy for tumor diagnosis
Krafft et al.	2005	Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors
Maziak et al.	2007	Fourier-transform infrared spectroscopic study of characteristic molecular structure in cancer cells of esophagus: an exploratory study
Andrus et al.	1998	Cancer grading by Fourier transform infrared spectroscopy
Choo et al.	1996	In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy
Wong et al.	1990	Infrared spectra of microtome sections of human colon tissues
US5891619A (en)	1999-04-06	System and method for mapping the distribution of normal and abnormal cells in sections of tissue
Krafft et al.	2004	Analysis of human brain tissue, brain tumors and tumor cells by infrared spectroscopic mapping
Conti et al.	2008	FT-IR microimaging spectroscopy: A comparison between healthy and neoplastic human colon tissues
Steiner et al.	2003	Distinguishing and grading human gliomas by IR spectroscopy
Wang et al.	2003	FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus
EP2577298B1 (fr)	2020-02-26	Diagnostic du cancer
Camerlingo et al.	2006	Wavelet data processing of micro-Raman spectra of biological samples
US20050250091A1 (en)	2005-11-10	Raman molecular imaging for detection of bladder cancer
Petter et al.	2009	Development and application of Fourier-transform infrared chemical imaging of tumour in human tissue
Guo et al.	2023	Precise diagnosis of lung cancer enabled by improved FTIR-based machine learning
Jackson et al.	1998	Cancer diagnosis by infrared spectroscopy: methodological aspects
Ramesh et al.	2001	FTIR microscopic studies on normal, polyp, and malignant human colonic tissues
Mehrotra et al.	2007	Infrared spectroscopic analysis of tumor pathology

CA2128190A1 - Methode d'identification de tissus - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (1)

Family

ID=4154015

Family Applications (1)

Country Status (1)

Cited By (2)

Cited By (2)

Similar Documents

Legal Events